| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone methyltransferase binding | 4.84e-05 | 18 | 80 | 3 | GO:1990226 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HIPK3 NOLC1 ASXL1 NCOA6 BIN1 PER2 SH2B3 DTL GON4L SIAH2 ZC3H18 SIN3A HDGFL2 MRTFA | 1.90e-04 | 1160 | 80 | 14 | GO:0030674 |
| GeneOntologyBiologicalProcess | cell division | NEK1 SETD2 MISP BRCA2 TTC28 BUB1 MASTL AKNA NUMB ZFYVE26 CLASP2 GAREM1 | 1.69e-05 | 697 | 81 | 12 | GO:0051301 |
| GeneOntologyBiologicalProcess | neuroblast division in subventricular zone | 4.56e-05 | 3 | 81 | 2 | GO:0021849 | |
| GeneOntologyBiologicalProcess | circadian regulation of translation | 9.09e-05 | 4 | 81 | 2 | GO:0097167 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.32e-04 | 66 | 81 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | monocyte homeostasis | 1.51e-04 | 5 | 81 | 2 | GO:0035702 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TOM1L2 NOLC1 SETD2 MISP BRCA2 TTC28 DTL BUB1 MASTL CUL9 ZFYVE26 CLASP2 SIN3A | 1.52e-04 | 1014 | 81 | 13 | GO:0000278 |
| GeneOntologyBiologicalProcess | negative regulation of hydrolase activity | 1.71e-04 | 298 | 81 | 7 | GO:0051346 | |
| GeneOntologyBiologicalProcess | chromatin organization | ASXL1 SETD2 UBN1 PER2 BRCA2 BUB1 PER1 DMRTC2 RRP8 SIN3A PRDM14 HDGFL2 | 1.87e-04 | 896 | 81 | 12 | GO:0006325 |
| GeneOntologyCellularComponent | centrosome | NEK1 MISP UBN1 TAPT1 BRCA2 TTC28 DTL CEP41 MASTL AKNA ZFYVE26 CLASP2 NCKAP5L | 7.72e-06 | 770 | 81 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule end | 1.40e-05 | 38 | 81 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | microtubule organizing center | NEK1 MISP UBN1 TAPT1 BRCA2 TTC28 DTL CEP41 MASTL AKNA ZFYVE26 CLASP2 NCKAP5L | 4.94e-05 | 919 | 81 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | microtubule plus-end | 1.71e-04 | 28 | 81 | 3 | GO:0035371 | |
| Domain | NCKAP5_C | 1.81e-05 | 2 | 80 | 2 | IPR032769 | |
| Domain | Nckap5l | 1.81e-05 | 2 | 80 | 2 | IPR026163 | |
| Domain | NCKAP5 | 1.81e-05 | 2 | 80 | 2 | PF15246 | |
| Domain | PAH | 5.42e-05 | 3 | 80 | 2 | IPR003822 | |
| Domain | - | 5.42e-05 | 3 | 80 | 2 | 1.20.1160.11 | |
| Domain | Period_circadian-like_C | 5.42e-05 | 3 | 80 | 2 | IPR022728 | |
| Domain | PAH | 5.42e-05 | 3 | 80 | 2 | PS51477 | |
| Domain | Period_C | 5.42e-05 | 3 | 80 | 2 | PF12114 | |
| Domain | PAH | 5.42e-05 | 3 | 80 | 2 | PF02671 | |
| Domain | NUT | 1.80e-04 | 5 | 80 | 2 | IPR024310 | |
| Domain | NUT_N | 1.80e-04 | 5 | 80 | 2 | IPR024309 | |
| Domain | NUT | 1.80e-04 | 5 | 80 | 2 | PF12881 | |
| Domain | PAS_fold_3 | 4.32e-03 | 23 | 80 | 2 | IPR013655 | |
| Domain | PAS_3 | 4.32e-03 | 23 | 80 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 4.70e-03 | 24 | 80 | 2 | IPR000700 | |
| Domain | PAC | 5.51e-03 | 26 | 80 | 2 | IPR001610 | |
| Domain | PAC | 5.51e-03 | 26 | 80 | 2 | SM00086 | |
| Domain | PAC | 5.51e-03 | 26 | 80 | 2 | PS50113 | |
| Domain | PAS | 8.27e-03 | 32 | 80 | 2 | SM00091 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B NCOA6 CRYBG2 DNAJC14 UBN1 PER2 SH2B3 ZNF516 PER1 AKNA CUL9 SIAH2 ZFYVE26 CLASP2 GAREM1 TRIM7 | 6.79e-09 | 1105 | 83 | 16 | 35748872 |
| Pubmed | Rhythmic changes in colonic motility are regulated by period genes. | 1.31e-08 | 3 | 83 | 3 | 19926812 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 8.19e-08 | 430 | 83 | 10 | 35044719 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 EVL NCOA6 SETD2 ESYT2 BIN1 UBN1 ZNF516 AFF1 ZC3H18 SIN3A MRTFA | 3.10e-07 | 774 | 83 | 12 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 NCOA6 NEK1 ESYT2 UBAP2 TTC28 SH3D19 PAK5 DTL NUMB CLASP2 NCKAP5L | 9.50e-07 | 861 | 83 | 12 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.42e-06 | 588 | 83 | 10 | 38580884 | |
| Pubmed | A molecular mechanism for circadian clock negative feedback. | 3.68e-06 | 13 | 83 | 3 | 21680841 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28710114 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23977055 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22236088 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22238756 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21793695 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27021954 | ||
| Pubmed | Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. | 5.63e-06 | 2 | 83 | 2 | 24551282 | |
| Pubmed | Constant darkness is a circadian metabolic signal in mammals. | 5.63e-06 | 2 | 83 | 2 | 16421573 | |
| Pubmed | Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. | 5.63e-06 | 2 | 83 | 2 | 11389837 | |
| Pubmed | Circadian regulation of central ethanol sensitivity by the mPer2 gene. | 5.63e-06 | 2 | 83 | 2 | 19523042 | |
| Pubmed | Cocaine sensitization and reward are under the influence of circadian genes and rhythm. | 5.63e-06 | 2 | 83 | 2 | 12084940 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11207804 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15009158 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35475497 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20370466 | ||
| Pubmed | cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. | 5.63e-06 | 2 | 83 | 2 | 18487196 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35810166 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23110090 | ||
| Pubmed | Circadian Modulation of Neurons and Astrocytes Controls Synaptic Plasticity in Hippocampal Area CA1. | 5.63e-06 | 2 | 83 | 2 | 33053337 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24603368 | ||
| Pubmed | The circadian clock protects against ionizing radiation-induced cardiotoxicity. | 5.63e-06 | 2 | 83 | 2 | 31919902 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12775559 | ||
| Pubmed | Circadian time-dependent tumor suppressor function of period genes. | 5.63e-06 | 2 | 83 | 2 | 19926612 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17996461 | ||
| Pubmed | Circadian gene expression is resilient to large fluctuations in overall transcription rates. | 5.63e-06 | 2 | 83 | 2 | 19078963 | |
| Pubmed | The circadian clock and tumor suppression by mammalian period genes. | 5.63e-06 | 2 | 83 | 2 | 15817328 | |
| Pubmed | Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing? | 5.63e-06 | 2 | 83 | 2 | 18367514 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21773940 | ||
| Pubmed | Homeostatic sleep regulation is preserved in mPer1 and mPer2 mutant mice. | 5.63e-06 | 2 | 83 | 2 | 12383239 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19477955 | ||
| Pubmed | Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects. | 5.63e-06 | 2 | 83 | 2 | 23351077 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23285241 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 34160105 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35460695 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12054191 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9920673 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36724252 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15959842 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19840112 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30452546 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17202855 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12693867 | ||
| Pubmed | Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. | 5.63e-06 | 2 | 83 | 2 | 23039899 | |
| Pubmed | Cones are required for normal temporal responses to light of phase shifts and clock gene expression. | 5.63e-06 | 2 | 83 | 2 | 20560710 | |
| Pubmed | Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice. | 5.63e-06 | 2 | 83 | 2 | 21624349 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 31260634 | ||
| Pubmed | Phase shifts and Per gene expression in mouse suprachiasmatic nucleus. | 5.63e-06 | 2 | 83 | 2 | 12824769 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12372028 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28286126 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26862173 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18786554 | ||
| Pubmed | Physiological and Molecular Dissection of Daily Variance in Exercise Capacity. | 5.63e-06 | 2 | 83 | 2 | 31006590 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36361751 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24091726 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30242505 | ||
| Pubmed | Deregulated expression of the Per1 and Per2 in human gliomas. | 5.63e-06 | 2 | 83 | 2 | 20481271 | |
| Pubmed | Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. | 5.63e-06 | 2 | 83 | 2 | 17971899 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33123539 | ||
| Pubmed | Time-place learning and memory persist in mice lacking functional Per1 and Per2 clock genes. | 5.63e-06 | 2 | 83 | 2 | 24336415 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23024437 | ||
| Pubmed | The circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels. | 5.63e-06 | 2 | 83 | 2 | 23608482 | |
| Pubmed | Circadian rhythms in Per1, PER2 and Ca2+ of a solitary SCN neuron cultured on a microisland. | 5.63e-06 | 2 | 83 | 2 | 31797953 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17715397 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36350921 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24770415 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27609640 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 31863649 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17055980 | ||
| Pubmed | Daily variation in global and local DNA methylation in mouse livers. | 5.63e-06 | 2 | 83 | 2 | 25689298 | |
| Pubmed | Per1/Per2 Disruption Reduces Testosterone Synthesis and Impairs Fertility in Elderly Male Mice. | 5.63e-06 | 2 | 83 | 2 | 35806403 | |
| Pubmed | Chronic circadian disturbance by a shortened light-dark cycle increases mortality. | 5.63e-06 | 2 | 83 | 2 | 22154820 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11121447 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12531511 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18346860 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TOM1L2 NOLC1 EVL NEK1 SETD2 CEP41 PER1 NUMB CLASP2 NCKAP5L MRTFA GAREM1 | 6.47e-06 | 1038 | 83 | 12 | 26673895 |
| Pubmed | 6.65e-06 | 549 | 83 | 9 | 38280479 | ||
| Pubmed | 1.13e-05 | 209 | 83 | 6 | 36779422 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.19e-05 | 211 | 83 | 6 | 24097068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 FAM193B NEK1 SETD2 DPYSL2 UBAP2 SH3D19 MASTL NUMB SIN3A HDGFL2 | 1.37e-05 | 934 | 83 | 11 | 33916271 |
| Pubmed | Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. | 1.69e-05 | 3 | 83 | 2 | 19013183 | |
| Pubmed | PER1 interaction with GPX1 regulates metabolic homeostasis under oxidative stress. | 1.69e-05 | 3 | 83 | 2 | 32896721 | |
| Pubmed | Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2. | 1.69e-05 | 3 | 83 | 2 | 11165242 | |
| Pubmed | Clock proteins and training modify exercise capacity in a daytime-dependent manner. | 1.69e-05 | 3 | 83 | 2 | 34426495 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29626648 | ||
| Pubmed | A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. | 1.69e-05 | 3 | 83 | 2 | 9428527 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26781276 | ||
| Pubmed | Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. | 1.69e-05 | 3 | 83 | 2 | 9427249 | |
| Pubmed | Association between polymorphisms in period genes and bone density in postmenopausal Korean women. | 1.69e-05 | 3 | 83 | 2 | 24678593 | |
| Pubmed | Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations. | 1.69e-05 | 3 | 83 | 2 | 27912059 | |
| Pubmed | Circadian Control of DRP1 Activity Regulates Mitochondrial Dynamics and Bioenergetics. | 1.69e-05 | 3 | 83 | 2 | 29478834 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30773466 | ||
| Pubmed | Photic entrainment of period mutant mice is predicted from their phase response curves. | 1.69e-05 | 3 | 83 | 2 | 20826680 | |
| Pubmed | A tunable artificial circadian clock in clock-defective mice. | 1.69e-05 | 3 | 83 | 2 | 26617050 | |
| Interaction | YWHAZ interactions | NOLC1 EVL DFFA ASXL1 NEK1 DPYSL2 BIN1 TXLNA PER2 SH2B3 TTC28 SH3D19 PAK5 DTL NUMB CLASP2 ZC3H18 NCKAP5L NOS1 GAREM1 TRIM7 | 3.58e-08 | 1319 | 81 | 21 | int:YWHAZ |
| Interaction | SPSB3 interactions | 1.45e-05 | 37 | 81 | 4 | int:SPSB3 | |
| Cytoband | 20q11 | 4.82e-05 | 6 | 83 | 2 | 20q11 | |
| Cytoband | 2q14 | 1.76e-04 | 11 | 83 | 2 | 2q14 | |
| Cytoband | 2q21.2 | 2.90e-04 | 14 | 83 | 2 | 2q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 1.92e-03 | 135 | 83 | 3 | chr8p21 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HIPK3 NCOA6 SETD2 HOXD1 PER2 SBNO1 PER1 GON4L NUMB ELK4 ARHGAP45 MRTFA GAREM1 | 1.56e-06 | 822 | 82 | 13 | M6782 |
| Coexpression | E2F1_UP.V1_UP | 2.80e-05 | 188 | 82 | 6 | M2632 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 3.54e-05 | 196 | 82 | 6 | M3243 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP | 3.96e-05 | 200 | 82 | 6 | M3850 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.65e-06 | 193 | 83 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| Drug | Methamphetamine | PCSK1 FAM193B DPYSL2 BIN1 LYPD1 HTR1A CSF1 PER2 MYOM1 POM121L12 SH3D19 DTL PER1 MASTL GON4L CUL9 SIAH2 CUBN NOS1 GFRA2 | 8.35e-08 | 1401 | 82 | 20 | ctd:D008694 |
| Drug | Mi-1 | 2.49e-06 | 8 | 82 | 3 | CID000198746 | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 7.41e-06 | 198 | 82 | 7 | 2234_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.91e-06 | 200 | 82 | 7 | 3907_DN | |
| Drug | CT 0 | 1.99e-05 | 15 | 82 | 3 | CID002255489 | |
| Disease | Myeloid Leukemia, Chronic | 5.95e-05 | 29 | 77 | 3 | C0023473 | |
| Disease | Malignant neoplasm of breast | EVL NCOA6 SETD2 CSF1 PER2 BRCA2 SBNO1 PER1 AFF1 ZFYVE26 CUBN | 1.05e-04 | 1074 | 77 | 11 | C0006142 |
| Disease | aspartate aminotransferase measurement | 1.19e-04 | 904 | 77 | 10 | EFO_0004736 | |
| Disease | Depression, Postpartum | 1.40e-04 | 7 | 77 | 2 | C0221074 | |
| Disease | lifestyle measurement, diastolic blood pressure | 1.40e-04 | 7 | 77 | 2 | EFO_0006336, EFO_0010724 | |
| Disease | vascular cell adhesion protein 1 measurement | 1.40e-04 | 7 | 77 | 2 | EFO_0020846 | |
| Disease | platelet crit | 1.81e-04 | 952 | 77 | 10 | EFO_0007985 | |
| Disease | myelofibrosis (is_implicated_in) | 1.86e-04 | 8 | 77 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | creatine kinase measurement | 5.00e-04 | 59 | 77 | 3 | EFO_0004534 | |
| Disease | Fetal Alcohol Spectrum Disorders | 5.15e-04 | 13 | 77 | 2 | C2985290 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.51e-04 | 61 | 77 | 3 | C1961102 | |
| Disease | monocyte count | TOM1L2 ASXL1 SETD2 CRYBG2 CSF1 SH2B3 ZNF516 GON4L ARHGAP45 GFRA2 MRTFA | 6.11e-04 | 1320 | 77 | 11 | EFO_0005091 |
| Disease | cancer | 6.30e-04 | 400 | 77 | 6 | MONDO_0004992 | |
| Disease | monocyte percentage of leukocytes | 6.38e-04 | 731 | 77 | 8 | EFO_0007989 | |
| Disease | MYELODYSPLASTIC SYNDROME | 7.26e-04 | 67 | 77 | 3 | C3463824 | |
| Disease | estrogen-receptor negative breast cancer | 8.60e-04 | 71 | 77 | 3 | EFO_1000650 | |
| Disease | Fetal Alcohol Syndrome | 8.91e-04 | 17 | 77 | 2 | C0015923 | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.12e-03 | 19 | 77 | 2 | C0349639 | |
| Disease | mean platelet volume | 1.34e-03 | 1020 | 77 | 9 | EFO_0004584 | |
| Disease | lymphocyte count | SETD2 UBAP2 CSF1 SH2B3 TTC28 SBNO1 AFF1 ELK4 ARHGAP45 GFRA2 MRTFA | 1.42e-03 | 1464 | 77 | 11 | EFO_0004587 |
| Disease | breast cancer, COVID-19 | 1.50e-03 | 22 | 77 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | Carcinoma of lung | 1.64e-03 | 23 | 77 | 2 | C0684249 | |
| Disease | testosterone measurement | 1.73e-03 | 1275 | 77 | 10 | EFO_0004908 | |
| Disease | lymphocyte percentage of leukocytes | 1.76e-03 | 665 | 77 | 7 | EFO_0007993 | |
| Disease | prostate carcinoma | 2.24e-03 | 891 | 77 | 8 | EFO_0001663 | |
| Disease | Fever | 2.26e-03 | 27 | 77 | 2 | C0015967 | |
| Disease | Colorectal Carcinoma | 2.38e-03 | 702 | 77 | 7 | C0009402 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.60e-03 | 713 | 77 | 7 | EFO_0005689 | |
| Disease | Bilateral Wilms Tumor | 2.61e-03 | 29 | 77 | 2 | C2930471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNLPSGKKISSNPNP | 546 | A0FGR8 | |
| CNKTLAPSPKSPGDF | 586 | O43683 | |
| GPPPKNKVLSNNASS | 31 | Q8N888 | |
| PNQIKSGTPYRTPKS | 711 | Q96GX5 | |
| PASCQQALPPGSARK | 271 | Q9BYV8 | |
| ASKASPPGDLQNPKR | 311 | O00273 | |
| SQSTPAKAPRAKCNP | 426 | Q9NZJ0 | |
| AKAPRAKCNPSNSSP | 431 | Q9NZJ0 | |
| APGAPQKNCKAVPSF | 1196 | Q8IXJ9 | |
| KGSPRPQAPKANGTS | 536 | Q14978 | |
| PRGPAKLPQSQSKSG | 351 | Q9P286 | |
| KQEASKPPRGCPQAN | 481 | Q8IVT2 | |
| PGAAAASKPNSTVPK | 671 | Q6Y2X3 | |
| SKKNRAGSPSPQPSG | 16 | Q92619 | |
| SKFGSQPIPAKRPAS | 281 | Q96PY6 | |
| SSPDQAPPQLSKSKG | 361 | Q9HCH0 | |
| GCAFLNPKFNPPKSS | 531 | Q09328 | |
| PTKFIKNPGSPSQSQ | 311 | Q9GZZ0 | |
| NPKQASLKRPPTAGA | 551 | Q9UBC5 | |
| ASSAKTSPAKQQAPP | 516 | Q16555 | |
| GTFKAKALPCQSPDP | 581 | O15534 | |
| DCKPGTSRDQQPKAP | 1021 | O15055 | |
| AASQPPNSSEAGRKP | 311 | Q9UI08 | |
| SYPRQKTPGTPKRNC | 651 | Q9H706 | |
| QPRPSAFKPLSKNGA | 211 | Q8N7R1 | |
| SSSGQSSPSPCKRPN | 921 | Q9H422 | |
| PQSSSTEPARKPGQK | 416 | Q7Z4V5 | |
| QSPTKNGSPSKCPRF | 291 | P29475 | |
| TPSPGRQNSKAPKLT | 1341 | Q14686 | |
| KFCGSKRPPNVKSSN | 3111 | O60494 | |
| PPKSKPYEGSQRNST | 1821 | Q9H7D0 | |
| PGSAKQRPPRSTCQS | 246 | P09603 | |
| SPAAQKAFQPPRSCG | 3291 | P51587 | |
| SPKAPNHFRKGTTQP | 106 | Q8IXT2 | |
| PGSNKVIKPNSGPSR | 431 | O00451 | |
| DKPPQPGAKTSSRND | 126 | P28324 | |
| GSQAKKSEASPAPRP | 721 | Q96PV7 | |
| SKNNRSFDTPVKGPP | 1636 | Q8TD84 | |
| PVPGQKNSSPTNFSK | 201 | Q8NEG2 | |
| KKTRSRECNNPPPSG | 516 | P10643 | |
| KGPCAPAASSPTQKE | 601 | Q8N1P7 | |
| NGRPPTAAAVPKSAK | 756 | Q5T3F8 | |
| SLQPSFNPGKTPARS | 1011 | Q3T8J9 | |
| RHGASPAPQPKKSVN | 241 | P08908 | |
| PSPKQRSKQAGSSPR | 1306 | Q7Z591 | |
| NINSPPPGDQARSKK | 116 | A6NNA5 | |
| CNGPRPKKRGSSASA | 106 | Q8N2G4 | |
| PQSPKAGKPSAAAAS | 116 | Q68CP4 | |
| PFSKNSKGRDRSPAP | 1446 | Q8IWT3 | |
| SPKAQRPVACPKGDS | 261 | Q8N8Q3 | |
| SDNAPAKGNKSPSPP | 286 | O00499 | |
| TAPSNNSSPRDSPCK | 686 | A3KN83 | |
| KPSLKDSGSRNPCPS | 76 | P0DN24 | |
| KSKQRTNPSPTNPFS | 626 | P49757 | |
| AQKRGLSPSPSPASK | 681 | A1L443 | |
| AQKRGLSPSPSPASK | 666 | Q5VZR2 | |
| GPKPSNQEGKSPARF | 181 | Q9GZV8 | |
| GKPSVAPKPAANRAS | 51 | Q5HYK7 | |
| QCPKSQTPGSRSRPA | 886 | O14513 | |
| TPRKCFVGQSKPNHP | 806 | Q9H156 | |
| LPKSYQQPKCTGRTP | 561 | Q96ST3 | |
| STGPSANKPCSKQPP | 6 | O43255 | |
| RPAGNPQNASRKKSP | 161 | A1L4H1 | |
| KPSPKTVCGSPLAAQ | 776 | Q969V6 | |
| GKRSCQKSPAQQEPP | 581 | P51825 | |
| AFKVPAPKTSGNPAN | 26 | O75122 | |
| APKTSGNPANSARKP | 31 | O75122 | |
| PDSLKAKFSAQPQGP | 971 | Q92618 | |
| QPKSQASKPAYGNSP | 1101 | Q5T6F2 | |
| KSTLSRCSNVPGPKP | 286 | Q9C029 | |
| DPPKSSRPKLQAACS | 241 | Q9UQQ2 | |
| ISRPPPAASSQNKGS | 21 | O43159 | |
| TTAGASPGPPRNKKN | 36 | O15213 | |
| KAGSPAPSNRLNDSP | 611 | Q9BYW2 | |
| PSPNSPFQKVGKLAS | 2116 | Q96AY4 | |
| SPFANKLQGPKASPT | 821 | Q9NPG3 | |
| PATCTPGKPSSKSQN | 471 | Q6NXT6 | |
| SSQKPGACAPKSPNQ | 76 | Q96LJ8 | |
| APASNPSGRKKPERS | 486 | Q6ZVM7 | |
| SRSPPEKPKQESQSC | 701 | Q68DK2 | |
| RPACQKANGFPPDKS | 41 | Q9Y4P3 | |
| AKQSNPKSSPGQPEA | 11 | P40222 | |
| SAKPPAGGKSSQQPS | 781 | Q86VM9 | |
| RASGSKPSPSPENKH | 1251 | Q9NR99 | |
| GSKPNKPSLPSSSQN | 876 | P52179 | |
| LQSAFSKNSPPKQSP | 671 | P29120 |